Cardiac Rhythm Management
banner AtriCure HRS 2019 hybridablation


tmb invite AtriCure HRS2019 hybridabl

San Francisco Marriott Marquis,
Yerba Buena Salons 1-4,
San Francisco, CA

Wednesday, May 8, 2019


11:45AM-12:15PM: Registration, followed by Plated Lunch
12:15PM-1:45PM: Educational Program

Cardiac Rhythm Management


11:45AM-12:15PM   Registration, followed by Plated Lunch
12:15PM-12:25PM   Historical Review of Convergent Data and Clinical Study Update
David DeLurgio, MD, FACC, FHRS
12:25PM-12:45PM   Advantage of Multidisciplinary Hybrid Ablation Technique:
A Surgeons Perspective

David Kress, MD, FACC, FACS
12:45PM-1:05PM   Role of Posterior Left Atrial Wall as an Important Ablation Target
Kevin Makati, MD, FACC, FHRS
1:05PM-1:25PM   Convergent AF Ablation Combined with LAA Closure
Felix Yang, MD, FACC, FHRS
1:25PM-1:45PM   Panel Discussion with Attendee Q&A
Moderator: David DeLurgio, MD, FACC, FHRS
Panel: David Kress, MD, FACC, FACS, Felix Yang, MD, FACC, FHRS,
Kevin Makati, MD, FACC, FHRS

Cardiac Rhythm Management

Commercial Support

This activity is supported through an educational grant from AtriCure.


Joint Providership
MediaSphere Medical, LLC and Ciné-Med



Program Director

David DeLurgio, MD, FACC, FHRS
Professor of Medicine
Division of Cardiology, Department of Medicine
Emory University School of Medicine
Atlanta, GA



David Kress, MD, FACC, FACS
Chief, Department of Cardiothoracic Surgery
Director, Surgical Arrhythmia Program
Aurora St. Luke’s Medical Center
Milwaukee, WI

Kevin Makati, MD, FACC, FHRS
Assistant Professor
Cardiology Section, Department of Medicine
University of South Florida School of Medicine
Rhythm Section Chair, BayCare Health Systems
Tampa, Florida


Felix Yang, MD, FACC, FHRS
Associate Director of Cardiac Electrophysiology
Maimonides Medical Center,
Brooklyn, NY




CME Activity Description

Activity Description
This educational activity has been developed to review current challenges and existing barriers that exist with traditional AF treatment strategies, and examine the emerging role of the multidisciplinary hybrid ablation approach as well as adjunctive LAA closure, through clinical trial reviews, outcomes data assessments, and case study presentations.

The expert faculty will thoroughly assess the impact that integrating electrophysiology and cardiac surgery in a hybrid AF treatment may have from improving patient outcomes, and will evaluate how to effectively establish new procedural and perioperative standards with the multidisciplinary approach.

Target Audience
The symposium is intended to meet the educational needs of electrophysiologists, cardiologists, fellows, and other physicians and associated healthcare professionals who are dedicated to the management of patients with Atrial Fibrillation.

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Review current challenges and existing barriers with traditional AF treatment strategies.
  • Examine the safety and efficacy of the Convergent procedural approach for treating Persistent or Longstanding Persistent AF.
  • Review the theoretical basis for targeting the posterior wall in NPAF patients.
  • Examine Convergent AF Ablation combined with LAA closure.

Accreditation Statement
Jointly Accredited Provider TMThis activity has been planned and implemented by Ciné-Med and MediaSphere Medical. Ciné-Med is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Ciné-Med designates this enduring activity for a maximum of 1.5 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity provides 1.5 contact hours for nurses.

Cardiac Rhythm Management

Disclosure Policy
MediaSphere Medical and Ciné-Med adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty’s commercial relationships will be made known at the activity on course hand-outs and during faculty presentations. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Faculty disclosures will be made available on the course syllabus book and faculty introductory slides.

Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.




“This program is not part of the Heart Rhythm 2019 Official Scientific Sessions as planned by the
Heart Rhythm Society Scientific Sessions Program Committee. The event is neither sponsored nor endorsed by the Heart Rhythm Society”